Austrian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 151 displayed.
1 2 3 4 5 6 7 8 »

Valneva Announces Positive Initial Results for Second Phase 2 Study of Lyme Disease Vaccine Candidate VLA15

Read more ››

By: GlobenewsWire - 20 Oct 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 19 Oct 2020

CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis

Read more ››

By: GlobenewsWire - 16 Oct 2020

Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation

Read more ››

By: GlobenewsWire - 16 Oct 2020

Emergent BioSolutions to Release Third Quarter 2020 Financial Results and Conduct Conference Call on November 5, 2020

Read more ››

By: GlobenewsWire - 15 Oct 2020

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies

Read more ››

By: GlobenewsWire - 15 Oct 2020

Dupixent® (dupilumab) significantly reduced severe asthma attacks in children and is the only biologic to demonstrate improvement in children’s lung function in a randomized Phase 3 trial

Read more ››

By: GlobenewsWire - 13 Oct 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 12 Oct 2020

Emergent BioSolutions’ COVID-19 Human Immune Globulin Product Candidate to be Included in NIH-Sponsored Phase 3 Clinical Trial of Hyperimmune Intravenous Immunoglobulin to Treat COVID-19

Read more ››

By: GlobenewsWire - 08 Oct 2020

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

Novo Nordisk raises sales and operating profit outlook for 2020

Read more ››

By: GlobenewsWire - 08 Oct 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 05 Oct 2020

EMA accepts regulatory submission for avalglucosidase alfa, a potentially new standard of care enzyme replacement therapy for Pompe disease

Read more ››

By: GlobenewsWire - 02 Oct 2020

Sanofi: Information concerning the total number of voting rights and shares - August 2020

Read more ››

By: GlobenewsWire - 01 Oct 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 28 Sep 2020

Sanofi completes Principia Biopharma Inc. acquisition

Read more ››

By: GlobenewsWire - 28 Sep 2020

Availability of the Q3 2020 Memorandum for modelling purposes

Read more ››

By: GlobenewsWire - 25 Sep 2020

THE LANCET publishes promising data of APEIRON's APN01 (rhsACE2) to treat COVID-19 in named patient use

VIENNA, Sept. 24, 2020 /PRNewswire/ -- APEIRON Biologics AG today announced that first, encouraging data with its clinical drug candidate APN01 (rhsACE2) to treat severe COVID-19 were published in the peer-reviewed journal The Lancet Respiratory Medicine (1).

Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020

Related companies: APEIRON Biologics AG

World’s largest study of cardiovascular disease in type 2 diabetes shows need for improved knowledge and disease management

Read more ››

By: GlobenewsWire - 24 Sep 2020

Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc.

Read more ››

By: GlobenewsWire - 22 Sep 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 21 Sep 2020

1 2 3 4 5 6 7 8 »

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

October 2020
- Biohealth Capital Region Investor Conference
- US Eastern Daylight Time: Europe CEO
- European Standard Time: BIO-Europe® 2020

Add an Event »

Latest company news

Valneva Announces Positive Initial Results for Second Phase 2 Study of Lyme Disease Vaccine Candidate VLA15
20 Oct 2020 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
19 Oct 2020 (GlobenewsWire)

CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis
16 Oct 2020 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Austrian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com